This Article Full Text Full Text (PDF) Supplemental Data All Versions of this Article: 149/4/1728    most recent Author Manuscript (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Yang, D. Articles by Bringhurst, F. R. Search for Related Content PubMed PubMed Citation Articles by Yang, D. Articles by Bringhurst, F. R.

CBP/p300-Interacting Protein CITED1 Modulates Parathyroid Hormone Regulation of Osteoblastic Differentiation

Endocrine Unit (D.Y., J.G., P.D., F.R.B.), Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114; and Molecular Profiling Laboratory (T.S.), Massachusetts General Hospital Cancer Center, Charlestown, Massachusetts 02129

Address all correspondence and requests for reprints to: F. R. Bringhurst, M.D., Endocrine Unit, Thier 11, Massachusetts General Hospital, Boston, Massachusetts 02114. E-mail: rbringhurst{at}partners.org.

PTH regulates osteoblastic differentiation and activity and exerts different overall skeletal effects in vivo, depending on the schedule and dose of administration. In clonal Wt9 murine osteoblastic cells, mRNA and protein levels of CITED1 transcriptional coactivator were strongly up-regulated by human (h) PTH(1–34). Stimulation of CITED1 mRNA by PTH was transient, peaking at 4 h, concentration dependent, and blocked by actinomycin D but not cycloheximide. The stimulation was mimicked by forskolin, phorbol ester, and the cAMP-selective PTH analog [G¹,R¹⁹] hPTH (1–28) and inhibited completely by the protein kinase A inhibitor, H89 and partially by phorbol ester-induced protein kinase C depletion. Increased CITED1 expression was not maintained during persistent (24 h) PTH exposure. Cultured primary calvarial osteoblasts from neonatal homozygous or hemizygous CITED1-knockout (KO) mice achieved 2-fold greater mineralized nodule formation in comparison with wild type (WT) osteoblasts. This effect was blocked by restoration of CITED1 expression via adenoviral gene transfer. Intermittent administration of hPTH(1–34) (10 nM, for 4 h every 48 h) for 3–6 wk increased mineralization up to 2-fold over basal levels in both WT and CITED1 KO mouse calvarial cell cultures. Whereas the cAMP-selective [G¹,R¹⁹]hPTH(1–28) analog [at 100 nM, equivalent to 10 nM hPTH(1–34)] did not stimulate mineralization in WT cultures, it was twice as effective as hPTH(1–34) in CITED1 KO cultures. Thus, CITED1 negatively regulates osteoblastic differentiation in vitro and inhibits the cAMP-dependent stimulation of differentiation by intermittent PTH. We conclude also that PTH receptor signaling pathways independent of cAMP restrain osteoblastic differentiation, an effect normally obscured in the presence of CITED1 but revealed in its absence.